Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2021

Open Access 01-12-2021 | Stroke | Research

Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials

Authors: Lisa J. Woodhouse, Alan A. Montgomery, Jonathan Mant, Barry R. Davis, Ale Algra, Jean-Louis Mas, Jan A. Staessen, Lutgarde Thijs, Andrew Tonkin, Adrienne Kirby, Stuart J. Pocock, John Chalmers, Graeme J. Hankey, J. David Spence, Peter Sandercock, Hans-Christoph Diener, Shinichiro Uchiyama, Nikola Sprigg, Philip M. Bath

Published in: BMC Medical Research Methodology | Issue 1/2021

Login to get access

Abstract

Background

Vascular prevention trials typically use dichotomous event outcomes although this may be inefficient statistically and gives no indication of event severity. We assessed whether ordinal outcomes would be more efficient and how to best analyse them.

Methods

Chief investigators of vascular prevention randomised controlled trials that showed evidence of either benefit or harm, or were included in a systematic review that overall showed benefit or harm, shared individual participant data from their trials. Ordered categorical versions of vascular event outcomes (such as stroke and myocardial infarction) were analysed using 15 statistical techniques and their results then ranked, with the result with the smallest p-value given the smallest rank. Friedman and Duncan’s multiple range tests were performed to assess differences between tests by comparing the average ranks for each statistical test.

Results

Data from 35 trials (254,223 participants) were shared with the collaboration. 13 trials had more than two treatment arms, resulting in 59 comparisons. Analysis approaches (Mann Whitney U, ordinal logistic regression, multiple regression, bootstrapping) that used ordinal outcome data had a smaller average rank and therefore appeared to be more efficient statistically than those that analysed the original binary outcomes.

Conclusions

Ordinal vascular outcome measures appear to be more efficient statistically than binary outcomes and provide information on the severity of event. We suggest a potential role for using ordinal outcomes in vascular prevention trials.
Appendix
Available only for authorised users
Literature
1.
4.
go back to reference Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–77. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–77.
18.
go back to reference Bath PMW, Geeganage CM, Gray LJ. Ordinal reanalysis of the SHEP trial. Stroke. 2008;39(9):E145-E. Bath PMW, Geeganage CM, Gray LJ. Ordinal reanalysis of the SHEP trial. Stroke. 2008;39(9):E145-E.
21.
go back to reference Woodhouse LJ, Montgomery AA, Bath PM. Improving the statistical analysis of vascular prevention trials: statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials. The optimising the analysis of vascular prevention trials collaboration (OA-prevention). PROSPERO. York: PROSPERO; 2019. Woodhouse LJ, Montgomery AA, Bath PM. Improving the statistical analysis of vascular prevention trials: statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials. The optimising the analysis of vascular prevention trials collaboration (OA-prevention). PROSPERO. York: PROSPERO; 2019.
23.
go back to reference Conover WJ. Practical nonparametric statistics. 2nd ed. New York: John Wiley & Sons; 1971. Conover WJ. Practical nonparametric statistics. 2nd ed. New York: John Wiley & Sons; 1971.
24.
go back to reference Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. 2 ed. Anker JD, editor. McGraw-Hill International Editions: Singapore; 1988. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. 2 ed. Anker JD, editor. McGraw-Hill International Editions: Singapore; 1988.
28.
go back to reference Stokes ME, Davis CS, Koch GG. Categorical data analysis using SAS: SAS institute; 2012. Stokes ME, Davis CS, Koch GG. Categorical data analysis using SAS: SAS institute; 2012.
32.
go back to reference Hollander M, Wolfe DA. Nonparametric statistical methods. New York: John Wiley & Sons inc; 1999. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: John Wiley & Sons inc; 1999.
39.
go back to reference Heart Protection Study Collaborative G. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22.CrossRef Heart Protection Study Collaborative G. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22.CrossRef
42.
go back to reference Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, et al. Intensive versus guideline antiplatelet therapy in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase III, superiority trial. Lancet. 2017. Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, et al. Intensive versus guideline antiplatelet therapy in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase III, superiority trial. Lancet. 2017.
Metadata
Title
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials
Authors
Lisa J. Woodhouse
Alan A. Montgomery
Jonathan Mant
Barry R. Davis
Ale Algra
Jean-Louis Mas
Jan A. Staessen
Lutgarde Thijs
Andrew Tonkin
Adrienne Kirby
Stuart J. Pocock
John Chalmers
Graeme J. Hankey
J. David Spence
Peter Sandercock
Hans-Christoph Diener
Shinichiro Uchiyama
Nikola Sprigg
Philip M. Bath
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2021
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-021-01388-6

Other articles of this Issue 1/2021

BMC Medical Research Methodology 1/2021 Go to the issue